Literature DB >> 23690225

Protection from oxidative and electrophilic stress in the Gsta4-null mouse heart.

Helen Beneš1, Mai K Vuong, Marjan Boerma, Kevin E McElhanon, Eric R Siegel, Sharda P Singh.   

Abstract

4-Hydroxynonenal (4-HNE) mediates many pathological effects of oxidative and electrophilic stress and signals to activate cytoprotective gene expression regulated by NF-E2-related factor 2 (Nrf2). By exhibiting very high levels of 4-HNE-conjugating activity, the murine glutathione transferase alpha 4 (GSTA4-4) helps regulate cellular 4-HNE levels. To examine the role of 4-HNE in vivo, we disrupted the murine Gsta4 gene. Gsta4-null mice exhibited no cardiac phenotype under normal conditions and no difference in cardiac 4-HNE level as compared to wild-type mice. We hypothesized that the Nrf2 pathway might contribute an important compensatory mechanism to remove excess cardiac 4-HNE in Gsta4-null mice. Cardiac nuclear extracts from Gsta4-null mice exhibited significantly higher Nrf2 binding to antioxidant response elements. We also observed responses in critical Nrf2 target gene products: elevated Sod2, Cat, and Akr1b7 mRNA levels and significant increases in both cardiac antioxidant and anti-electrophile enzyme activities. Gsta4-null mice were less sensitive and maintained normal cardiac function following chronic doxorubicin treatment, known to increase cardiac 4-HNE levels. Hence, in the absence of GSTA4-4 to modulate both physiological and pathological 4-HNE levels, the adaptive Nrf2 pathway may be primed to contribute to a preconditioned cardiac phenotype in the Gsta4-null mouse.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23690225      PMCID: PMC3796146          DOI: 10.1007/s12012-013-9215-1

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  68 in total

1.  Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.

Authors:  Carole Richard; Steliana Ghibu; Stéphanie Delemasure-Chalumeau; Jean-Claude Guilland; Christine Des Rosiers; Marianne Zeller; Yves Cottin; Luc Rochette; Catherine Vergely
Journal:  J Pharmacol Exp Ther       Date:  2011-09-20       Impact factor: 4.030

2.  Effects of interventions on oxidative stress and inflammation of cardiovascular diseases.

Authors:  Sewon Lee; Yoonjung Park; Mozow Yusof Zuidema; Mark Hannink; Cuihua Zhang
Journal:  World J Cardiol       Date:  2011-01-26

3.  Doxorubicin-induced acute changes in cytotoxic aldehydes, antioxidant status and cardiac function in the rat.

Authors:  X Luo; Y Evrovsky; D Cole; J Trines; L N Benson; D C Lehotay
Journal:  Biochim Biophys Acta       Date:  1997-02-27

4.  Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.

Authors:  Youyou Zhao; Declan McLaughlin; Emma Robinson; Adam P Harvey; Michelle B Hookham; Ajay M Shah; Barbara J McDermott; David J Grieve
Journal:  Cancer Res       Date:  2010-09-30       Impact factor: 12.701

5.  Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury.

Authors:  Luksana Chaiswing; Marsha P Cole; Daret K St Clair; Wanida Ittarat; Luke I Szweda; Terry D Oberley
Journal:  Toxicol Pathol       Date:  2004 Sep-Oct       Impact factor: 1.902

6.  Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2.

Authors:  Eric N Churchill; Marie-Hélène Disatnik; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2008-10-17       Impact factor: 5.000

7.  Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice.

Authors:  Tamara Raphael Knight; Supratim Choudhuri; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2007-09-22       Impact factor: 4.849

8.  Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.

Authors:  Kyoung-Han Kim; Gavin Y Oudit; Peter H Backx
Journal:  J Pharmacol Exp Ther       Date:  2007-10-10       Impact factor: 4.030

9.  Mechanism of chemical activation of Nrf2.

Authors:  Yun Li; Joseph D Paonessa; Yuesheng Zhang
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

10.  Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress.

Authors:  Ronald C Taylor; George Acquaah-Mensah; Mudita Singhal; Deepti Malhotra; Shyam Biswal
Journal:  PLoS Comput Biol       Date:  2008-08-29       Impact factor: 4.475

View more
  9 in total

1.  Sulforaphane protects the heart from doxorubicin-induced toxicity.

Authors:  Preeti Singh; Rajendra Sharma; Kevin McElhanon; Charles D Allen; Judit K Megyesi; Helen Beneš; Sharda P Singh
Journal:  Free Radic Biol Med       Date:  2015-05-27       Impact factor: 7.376

2.  Effects of Local Heart Irradiation in a Glutathione S-Transferase Alpha 4-Null Mouse Model.

Authors:  Marjan Boerma; Preeti Singh; Vijayalakshmi Sridharan; Preeti Tripathi; Sunil Sharma; Sharda P Singh
Journal:  Radiat Res       Date:  2015-05-26       Impact factor: 2.841

3.  Role of the pregnane X receptor in binge ethanol-induced steatosis and hepatotoxicity.

Authors:  Sora Choi; Afua A Gyamfi; Prince Neequaye; Samuel Addo; Frank J Gonzalez; Maxwell A Gyamfi
Journal:  J Pharmacol Exp Ther       Date:  2018-02-05       Impact factor: 4.030

4.  Maternal Plane of Nutrition during Late Gestation and Weaning Age Alter Angus × Simmental Offspring Longissimus Muscle Transcriptome and Intramuscular Fat.

Authors:  Sonia J Moisá; Daniel W Shike; Lindsay Shoup; Sandra L Rodriguez-Zas; Juan J Loor
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

5.  Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.

Authors:  Chhanda Bose; Sanjay Awasthi; Rajendra Sharma; Helen Beneš; Martin Hauer-Jensen; Marjan Boerma; Sharda P Singh
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

6.  Sulforaphane prevents age-associated cardiac and muscular dysfunction through Nrf2 signaling.

Authors:  Chhanda Bose; Ines Alves; Preeti Singh; Philip T Palade; Eugenia Carvalho; Elisabet Børsheim; Se-Ran Jun; Amrita Cheema; Marjan Boerma; Sanjay Awasthi; Sharda P Singh
Journal:  Aging Cell       Date:  2020-10-17       Impact factor: 9.304

7.  Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway.

Authors:  Yuzhou Liu; Liying Zhou; Binbin Du; Yuan Liu; Junhui Xing; Sen Guo; Ling Li; Hongrui Chen
Journal:  Oxid Med Cell Longev       Date:  2021-08-06       Impact factor: 6.543

8.  Proteomic Analysis of Cardiac Adaptation to Exercise by High Resolution Mass Spectrometry.

Authors:  Afnan Saleh Al-Menhali; Cali Anderson; Alexander V Gourine; Andrey Y Abramov; Alicia D'Souza; Morana Jaganjac
Journal:  Front Mol Biosci       Date:  2021-09-01

9.  N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice.

Authors:  Saravanan S Karuppagounder; Lauren Alin; Yingxin Chen; David Brand; Megan W Bourassa; Kristen Dietrich; Cassandra M Wilkinson; Colby A Nadeau; Amit Kumar; Steve Perry; John T Pinto; Victor Darley-Usmar; Stephanie Sanchez; Ginger L Milne; Domenico Pratico; Theodore R Holman; S Thomas Carmichael; Giovanni Coppola; Frederick Colbourne; Rajiv R Ratan
Journal:  Ann Neurol       Date:  2018-11-29       Impact factor: 10.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.